Literature DB >> 35641841

Fluorescein application in spinal ependymomas: have we come so far?

Lucas Serra Sant'Anna1, Raphael Sepúlvida1, Rafael Abbud1, Rafael Teixeira Magalhães Leal1, Marcus André Acioly2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35641841     DOI： 10.1007/s10143-022-01821-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   2.800


× No keyword cloud information.
  3 in total

1.  Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective Study.

Authors:  Francesco Acerbi; Claudio Cavallo; Karl-Michael Schebesch; Mehmet Osman Akçakaya; Camilla de Laurentis; Mustafa Kemal Hamamcioglu; Morgan Broggi; Alexander Brawanski; Jacopo Falco; Roberto Cordella; Paolo Ferroli; Talat Kiris; Julius Höhne
Journal:  World Neurosurg       Date:  2017-09-19       Impact factor: 2.104

2.  Application of sodium fluorescein for spinal cord lesions: intraoperative localization for tissue biopsy and surgical resection.

Authors:  Timothy H Ung; Stephanie Serva; Grégoire P Chatain; Jens-Peter Witt; Michael Finn
Journal:  Neurosurg Rev       Date:  2021-10-27       Impact factor: 3.042

3.  Fluorescein Application in Cranial and Spinal Tumors Enhancing at Preoperative MRI and Operated With a Dedicated Filter on the Surgical Microscope: Preliminary Results in 279 Patients Enrolled in the FLUOCERTUM Prospective Study.

Authors:  Jacopo Falco; Claudio Cavallo; Ignazio G Vetrano; Camilla de Laurentis; Lampros Siozos; Marco Schiariti; Morgan Broggi; Paolo Ferroli; Francesco Acerbi
Journal:  Front Surg       Date:  2019-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.